What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
His main research concerns Heme oxygenase, Angiogenesis, Cell biology, Vascular endothelial growth factor and Heme.
His Heme oxygenase research is multidisciplinary, relying on both Tumor necrosis factor alpha, Molecular biology and Cancer research.
His research integrates issues of Inflammation, Immunology, Tube formation and Hypoxia in his study of Angiogenesis.
As part of his studies on Cell biology, Jozef Dulak frequently links adjacent subjects like Transcription factor.
In his study, which falls under the umbrella issue of Vascular endothelial growth factor, Activator, Transfection and Nitric oxide synthase is strongly linked to Endothelium.
Jozef Dulak is involved in the study of Heme that focuses on Biliverdin in particular.
His most cited work include:
- Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism (736 citations)
- Function of Mitochondrial Stat3 in Cellular Respiration (679 citations)
- HMG-CoA Reductase Inhibitors Regulate Inflammatory Transcription Factors in Human Endothelial and Vascular Smooth Muscle Cells (296 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Cell biology, Heme oxygenase, Angiogenesis, Cancer research and Vascular endothelial growth factor.
Jozef Dulak focuses mostly in the field of Cell biology, narrowing it down to topics relating to Transcription factor and, in certain cases, Regulation of gene expression.
Jozef Dulak has included themes like Oxidative stress and Molecular biology in his Heme oxygenase study.
His Angiogenesis study combines topics from a wide range of disciplines, such as Endothelial stem cell, Endothelium, Immunology and Pharmacology.
His research in Cancer research focuses on subjects like Progenitor cell, which are connected to Bone marrow.
His Vascular endothelial growth factor research incorporates elements of Endocrinology and Nitric oxide.
He most often published in these fields:
- Cell biology (30.52%)
- Heme oxygenase (29.22%)
- Angiogenesis (30.84%)
What were the highlights of his more recent work (between 2015-2021)?
- Cell biology (30.52%)
- Heme oxygenase (29.22%)
- Angiogenesis (30.84%)
In recent papers he was focusing on the following fields of study:
Jozef Dulak mainly investigates Cell biology, Heme oxygenase, Angiogenesis, Cancer research and HMOX1.
The study incorporates disciplines such as Endothelial stem cell, Oxidative stress, Transcription factor and Induced pluripotent stem cell in addition to Cell biology.
His Heme oxygenase study is concerned with the larger field of Biochemistry.
His Angiogenesis study incorporates themes from Progenitor cell, Vascular endothelial growth factor and In vivo.
In his research, Clonogenic assay is intimately related to Cancer cell, which falls under the overarching field of Cancer research.
Jozef Dulak works mostly in the field of HMOX1, limiting it down to concerns involving Endocrinology and, occasionally, Proinflammatory cytokine.
Between 2015 and 2021, his most popular works were:
- Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism (736 citations)
- TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation (130 citations)
- MCPIP1 contributes to clear cell renal cell carcinomas development. (41 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
The scientist’s investigation covers issues in Heme oxygenase, Cell biology, HMOX1, Cancer research and Angiogenesis.
The various areas that Jozef Dulak examines in his Heme oxygenase study include Inflammation, Immunology and MyoD.
His study in the fields of Stem cell under the domain of Cell biology overlaps with other disciplines such as Clear cell renal cell carcinoma.
Jozef Dulak combines subjects such as Endocrinology, Internal medicine, Monocyte, Skeletal muscle and Downregulation and upregulation with his study of HMOX1.
His Cancer research research is multidisciplinary, incorporating perspectives in Bladder cancer, Cancer, Hypoxia-inducible factors, Pathology and miR-155.
In his study, Phenotype, Dystrophy and Disease is inextricably linked to Vascular endothelial growth factor, which falls within the broad field of Angiogenesis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
